162 related articles for article (PubMed ID: 6607219)
1. Virulence factors of Haemophilus ducreyi.
Odumeru JA; Wiseman GM; Ronald AR
Infect Immun; 1984 Feb; 43(2):607-11. PubMed ID: 6607219
[TBL] [Abstract][Full Text] [Related]
2. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility of Haemophilus ducreyi.
Hammond GW; Lian CJ; Wilt JC; Ronald AR
Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
[TBL] [Abstract][Full Text] [Related]
4. Iron and virulence of Haemophilus ducreyi in a primate model.
Sturm AW
Sex Transm Dis; 1997 Feb; 24(2):64-8. PubMed ID: 9111750
[TBL] [Abstract][Full Text] [Related]
5. Serum resistance in Haemophilus ducreyi requires outer membrane protein DsrA.
Elkins C; Morrow KJ; Olsen B
Infect Immun; 2000 Mar; 68(3):1608-19. PubMed ID: 10678980
[TBL] [Abstract][Full Text] [Related]
6. Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.
Odumeru JA; Wiseman GM; Ronald AR
Infect Immun; 1985 Nov; 50(2):495-9. PubMed ID: 3876995
[TBL] [Abstract][Full Text] [Related]
7. Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.
Spinola SM; Li W; Fortney KR; Janowicz DM; Zwickl B; Katz BP; Munson RS
Infect Immun; 2012 Feb; 80(2):679-87. PubMed ID: 22144477
[TBL] [Abstract][Full Text] [Related]
8. A Haemophilus ducreyi CpxR deletion mutant is virulent in human volunteers.
Labandeira-Rey M; Dodd D; Fortney KR; Zwickl B; Katz BP; Janowicz DM; Spinola SM; Hansen EJ
J Infect Dis; 2011 Jun; 203(12):1859-65. PubMed ID: 21606544
[TBL] [Abstract][Full Text] [Related]
9. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes.
Steed LL; Setareh M; Friedman RL
J Leukoc Biol; 1991 Oct; 50(4):321-30. PubMed ID: 1919361
[TBL] [Abstract][Full Text] [Related]
10. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the lspA1 and lspA2 genes of Haemophilus ducreyi affect the virulence of this pathogen in an animal model system.
Ward CK; Latimer JL; Nika J; Vakevainen M; Mock JR; Deng K; Blick RJ; Hansen EJ
Infect Immun; 2003 May; 71(5):2478-86. PubMed ID: 12704119
[TBL] [Abstract][Full Text] [Related]
12. Shigella sonnei phase I and phase II: susceptibility to direct serum lysis and opsonic requirements necessary for stimulation of leukocyte redox metabolism and killing.
Madonna GS; Allen RC
Infect Immun; 1981 Apr; 32(1):153-9. PubMed ID: 7012027
[TBL] [Abstract][Full Text] [Related]
13. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
Lagergård T
Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
[TBL] [Abstract][Full Text] [Related]
14. Neutropenia restores virulence to an attenuated Cu,Zn superoxide dismutase-deficient Haemophilus ducreyi strain in the swine model of chancroid.
San Mateo LR; Toffer KL; Orndorff PE; Kawula TH
Infect Immun; 1999 Oct; 67(10):5345-51. PubMed ID: 10496915
[TBL] [Abstract][Full Text] [Related]
15. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants.
Hiltke TJ; Bauer ME; Klesney-Tait J; Hansen EJ; Munson RS; Spinola SM
Microb Pathog; 1999 Feb; 26(2):93-102. PubMed ID: 10090856
[TBL] [Abstract][Full Text] [Related]
16. Resistance of Pasteurella multocida to rabbit neutrophil phagocytosis and killing.
Rush HG; Glorioso JC; DaRif CA; Olson LC
Am J Vet Res; 1981 Oct; 42(10):1760-8. PubMed ID: 7325438
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil degranulation induced by Haemophilus ducreyi.
Odhav B; Hoosen A; Sturm W
Biol Chem; 2001 May; 382(5):825-30. PubMed ID: 11517937
[TBL] [Abstract][Full Text] [Related]
18. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.
Janowicz DM; Fortney KR; Katz BP; Latimer JL; Deng K; Hansen EJ; Spinola SM
Infect Immun; 2004 Aug; 72(8):4528-33. PubMed ID: 15271912
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems.
Lewis DA; Stevens MK; Latimer JL; Ward CK; Deng K; Blick R; Lumbley SR; Ison CA; Hansen EJ
Infect Immun; 2001 Sep; 69(9):5626-34. PubMed ID: 11500438
[TBL] [Abstract][Full Text] [Related]
20. A hemoglobin-binding outer membrane protein is involved in virulence expression by Haemophilus ducreyi in an animal model.
Stevens MK; Porcella S; Klesney-Tait J; Lumbley S; Thomas SE; Norgard MV; Radolf JD; Hansen EJ
Infect Immun; 1996 May; 64(5):1724-35. PubMed ID: 8613384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
